Nano-Check Influenza A+B Test

SKU: MD8153

In Stock

Flu A&B

Rapid 15-Minute Results

Differentiates Flu A & Flu B

CLIA Waived & Easy To Use

CLIA license Required to purchase this product

$150.00

$6.00 USD per test (25 test per box)

Volume Discounts

10-20 boxes $135.00 per box ($5.40 per test)

21-39 boxes $130.50 per box ($5.22 per test)

40-49 boxes $127.50 per box ($5.10 per test)

50+ boxes Request Bulk Discount

Quantity:

Request Bulk Pricing Download Product Brochure Download Product Insert

Prepare the extraction tube. Empty the entire extraction-buffer ampule into the provided reagent tube. Confirm that the liquid level is at or above Line 1, then securely attach the dropper tip.
Collect the nasal specimen. Tilt the patient's head back approximately 70°. Insert the supplied swab no more than ¾ inch into the nostril—no more than ½ inch for a child. Rotate the swab against the inside wall of the nostril at least 5 times over approximately 15 seconds. Repeat in the other nostril using the same swab.
Extract the specimen. Tap the reagent tube vertically and remove the dropper tip. Insert the swab until the swab head reaches the bottom of the tube. Squeeze the tube around the swab head and stir the swab at least 15 times.
Remove the swab. While squeezing the sides of the tube, remove the swab to express as much liquid as possible from the swab head. Replace the dropper tip securely and dispose of the swab appropriately.
Apply the sample. Hold the tube vertically and dispense 2 drops of the extracted sample into the sample-loading well of the test device. The sample should be applied within 30 minutes of completing the extraction step.
Read the result. Wait 15 minutes and visually interpret the test. Do not read results before 15 minutes or after 20 minutes. The CON control line must appear for the test to be valid. A line at A indicates Influenza A, a line at B indicates Influenza B, and lines at both A and B indicate a possible dual-positive result.

The Nano-Check™ Influenza A+B Test is a rapid lateral flow immunochromatographic assay designed for the qualitative detection and differentiation of Influenza A and Influenza B nucleoprotein antigens from anterior nasal swab specimens in patients showing signs and symptoms of respiratory infection. It is intended to aid healthcare professionals in the differential diagnosis of Influenza A and Influenza B infections.

The test provides visually readable results in approximately 15 minutes and is designed for use with the anterior nasal swabs supplied in the kit. It is CLIA waived for anterior nasal swab testing, intended for prescription and in vitro diagnostic use, and requires no specialized laboratory instrumentation. Each kit contains 25 tests, along with extraction buffer, sample collection swabs, and positive and negative control swabs.

Clinical testing reported a Positive Percent Agreement of 86.9% for Influenza A and 86.8% for Influenza B, with Negative Percent Agreement of 99.6% and 99.7%, respectively, compared with an FDA-cleared RT-PCR method.